CollPlant Launches US Logistics Hub to Support North American Growth

CollPlant Biotechnologies has expanded its North American operations through a new partnership with a US-based logistics hub, the company announced. The center, expected to become operational this quarter, will support the growing distribution needs for CollPlant’s recombinant human collagen (rhCollagen) and BioInk product lines in the US and Canada.

The new facility will provide current Good Manufacturing Practice (cGMP)—compliant storage and clinical supply distribution. According to CollPlant, it will feature controlled environments, a cloud-based temperature monitoring system, artificial intelligence-powered security, and remote inventory management capabilities.

CollPlant emphasized the role of the logistics center in strengthening customer service and supply reliability across the region.

“The establishment of a US logistics center demonstrates our long-term commitment to the North American market and represents an important milestone in advancing regenerative medicine products based on our rhCollagen technology,” said Yehiel Tal, Chief Executive Officer of CollPlant. “This center is expected to increase efficiency and reduce shipping time, ensuring our customers experience uninterrupted access to our products.”

The announcement aligns with the company’s ongoing efforts to scale its regenerative and aesthetic medicine platforms through strategic infrastructure investments.